Eczema, a chronic skin condition, often requires a unique and personalized approach to treatment. It’s not just about finding the right medication or therapy; it’s about building a relationship between healthcare providers (HCPs) and patients. This relationship, founded on trust, empathy, and collaboration, is at the heart of shared decision-making (SDM) – a process that… Read More
The Emergence of TYK2 Inhibitors in Psoriasis Treatment: A Synopsis
Key Takeaways: Psoriasis remains undertreated in the US due to factors such as concerns about side effects, monitoring requirements, and the use of injectable treatments. TYK2 inhibitors, like orally administered deucravacitinib, represent a promising new treatment option for psoriasis. Numerous hurdles, including treatment costs, specialist availability, insurance coverage, and safety concerns need addressing for effective… Read More